Summit Therapeutics Inc.
2021 Q2 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 127 | 0.0% | 7,270 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 152 | 0.0% | 7,373 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 157 | 0.0% | 7,368 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 88 | 0.0% | 4,540 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 120 | 0.0% | 6,740 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 140 | 0.0% | 6,384 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 49 | 0.0% | 6,343 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 570 | 0.0% | 137,646 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 374 | 0.0% | 143,249 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 279 | 0.0% | 149,001 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 405 | 0.0% | 161,287 | 6/30/2023 |
| 2022 Q1 | 5/16/2022 | 27 | 0.0% | 11,186 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 37 | 0.0% | 13,671 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 71 | 0.0% | 14,248 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 233 | 0.0% | 31,265 | 6/30/2021 |